Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesWages, Salaries and Other
Ratios

Coeptis Therapeutics Holdings (COEP) Depreciation & Amortization (IS) (2022 - 2025)

Historic Depreciation & Amortization (IS) for Coeptis Therapeutics Holdings (COEP) over the last 4 years, with Q2 2025 value amounting to $250000.0.

  • Coeptis Therapeutics Holdings' Depreciation & Amortization (IS) changed 0.0% to $250000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $1.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.0 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Depreciation & Amortization (IS) of $250000.0 as of Q2 2025, which was down 0.0% from $250000.0 recorded in Q1 2025.
  • Coeptis Therapeutics Holdings' 5-year Depreciation & Amortization (IS) high stood at $250346.0 for Q4 2022, and its period low was $250000.0 during Q1 2023.
  • Over the past 4 years, Coeptis Therapeutics Holdings' median Depreciation & Amortization (IS) value was $250000.0 (recorded in 2023), while the average stood at $250034.6.
  • In the last 5 years, Coeptis Therapeutics Holdings' Depreciation & Amortization (IS) dropped by 13.82% in 2023 and then changed by 0.0% in 2024.
  • Quarter analysis of 4 years shows Coeptis Therapeutics Holdings' Depreciation & Amortization (IS) stood at $250346.0 in 2022, then fell by 0.14% to $250000.0 in 2023, then changed by 0.0% to $250000.0 in 2024, then changed by 0.0% to $250000.0 in 2025.
  • Its last three reported values are $250000.0 in Q2 2025, $250000.0 for Q1 2025, and $250000.0 during Q4 2024.